Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Survival outcomes in patients with resectable gastric cancer treated with total neoadjuvant therapy.
Authors
Yun Song
The University of Texas MD Anderson Cancer Center, Houston, TX
Yun Song , Yuki Hirata , Jaffer A. Ajani , Mariela A. Blum Murphy , Jenny Jing Li , Prajnan Das , Bruce D. Minsky , Paul F. Mansfield , Naruhiko Ikoma , Brian D. Badgwell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 338)
DOI
10.1200/JCO.2024.42.3_suppl.338
Abstract #
338
Poster Bd #
F18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Phase I trial of short-course chemoradiotherapy followed by chemotherapy as total neoadjuvant therapy for patients with potentially resectable gastric cancer.
First Author: Brian D. Badgwell
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Survival outcome and treatment response of patients with young-onset locally advanced rectal cancer (YO-LARC) receiving total neoadjuvant therapy (TNT).
First Author: Edward McKenna
Poster
2020 Gastrointestinal Cancers Symposium
Perioperative FLOT in resectable gastric cancer: Italian real-world data from the RealFLOT study.
First Author: Elisa Giommoni
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang